These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27738381)

  • 1. Valproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.
    Mnif L; Sellami R; Masmoudi J
    Psychopharmacol Bull; 2016 Aug; 46(2):59-62. PubMed ID: 27738381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
    Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
    J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute pancreatitis induced by valproic acid].
    Jomli R; Nacef F; Douki S
    Encephale; 2013 Sep; 39(4):292-5. PubMed ID: 23541917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenomics of valproic acid.
    Zhu MM; Li HL; Shi LH; Chen XP; Luo J; Zhang ZL
    J Hum Genet; 2017 Dec; 62(12):1009-1014. PubMed ID: 28878340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with valproate and hepatic steatosis].
    Ortiz-Sáenz de Santa María R; Santiago-Fernández C; Cano-Del Pozo M; Pérez-Gil O; Soto-Alvarez MI; Barriuso-Pérez E; Moche-Loeri JA
    Rev Neurol; 2005 Dec 16-31; 41(12):766-7. PubMed ID: 16355364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valproic acid toxicity due to misinterpretation of plasma levels: increase in unbound fraction caused by hypoalbuminaemia and renal dysfunction].
    Ruiter-Visser R; Dols A; Smulders YM; Jacobs GE; Nauta KJ
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valproic acid on dementia onset in patients with bipolar disorder.
    Tsai PS; Liu IC; Chiu CH; Huang CJ; Wang MY
    J Affect Disord; 2016 Sep; 201():131-6. PubMed ID: 27208500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant hypersensitivity syndrome from addition of lamotrigine to divalproex.
    Rahman M; Haider N
    Am J Psychiatry; 2005 May; 162(5):1021. PubMed ID: 15863816
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy.
    Scott DA; Gholson CF; Netchvolodoff CV; Ray M; Gonzalez E; Bacon BR
    Am J Gastroenterol; 1991 Apr; 86(4):500-2. PubMed ID: 1901443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic Acid and hypersensitivity syndrome.
    Roepke S; Treudler R; Anghelescu I; Orfanos CE; Tebbe B
    Am J Psychiatry; 2004 Mar; 161(3):579. PubMed ID: 14992991
    [No Abstract]   [Full Text] [Related]  

  • 11. Re:Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy.
    Baillie J; Baillie TA
    Am J Gastroenterol; 1992 Sep; 87(9):1225-6. PubMed ID: 1519593
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH; Chien YL
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
    Muzyk AJ; Candeloro CL; Christopher EJ
    Gen Hosp Psychiatry; 2010; 32(5):560.e1-3. PubMed ID: 20851283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem-induced Valproic Acid Elimination: A Case Report of Clinically Relevant Drug Interaction.
    Šíma M; Hartinger J; Rulíšek J; Šachl R; Slanař O
    Prague Med Rep; 2017; 118(2-3):105-109. PubMed ID: 28922108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hepatic steatosis. Description of a clinical case of sodium valproate-induced acute hepatic steatosis].
    Coraggio F; Angiulli B; Carbone M; Catalano A; Costa MR; Gargiulo L; Gentile B; Masetto O; Pomponio N; Scarpato P
    Clin Ter; 1988 Mar; 124(6):451-63. PubMed ID: 2974353
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of acute pancreatitis caused by sodium valproate in a patient with bipolar disorder on hemodialysis for chronic renal failure: a case report.
    Okayasu H; Shinozaki T; Osone A; Ozeki Y; Shimoda K
    BMC Psychiatry; 2014 Mar; 14():93. PubMed ID: 24679075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticonvulsants in the treatment of bipolar disorder].
    Grunze H
    Neuropsychiatr; 2007; 21(2):110-20. PubMed ID: 17640497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we prevent fatal liver failure under valproate?
    Schmid MM; Connemann BJ; Wolf RC; Flechtenmacher C; Eisenbach C; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2010 Jul; 43(5):198-200. PubMed ID: 20503151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.